Related Experiment Video
Updated: Jun 27, 2026

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue
Published on: August 28, 2021
Sensitive quantitation of reboxetine enantiomers in rat plasma and brain, using an optimised reverse phase chiral
Paul Turnpenny1, Daniela Fraier
1Discovery Bioanalytical Group, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, Sandwich, Kent CT13 9NJ, UK. paul.turnpenny@pfizer.com
Abstract:
A sensitive liquid chromatography-mass spectrometry (LC-MS) method has been developed for stereoselective determination of reboxetine in rat plasma and brain homogenate (LLOQ, 50 pg/ml). The method optimised ionisation efficiency with an electro-ionspray source, by adjusting the composite flow conditions (rate, pH, organic content) from column eluent and post-column organic modifier. LC conditions utilized a chiral AGP column (5 microm) with 12.5 mM ammonium carbonate buffer adjusted with formic acid (pH 6.7) and included a wash step (0.05% acetic acid in water) to maintain assay robustness and chromatographic performance. The total method cycle time was 23 min. Imprecision (R.S.D.) was below 10% and inaccuracy (% error) below 7% for both enantiomers in plasma and brain homogenate, over a 2000-fold dynamic range (0.05-100 ng/ml). An automated liquid-liquid extraction technique was used (borate buffer, pH 10/tert-butyl methyl ether) and the matrix type used produced no difference in the assay performance. The method was successfully applied to determine the pharmacokinetic profiles of S,S- and R,R-reboxetine in rats, following subcutaneous administration of racemate drug.

